Myocardial protection via the coronary sinus.
BACKGROUND
Recent reports on facilitated reperfusion therapy re-address interests in coronary sinus interventions (CSI). Patients in whom short time results have been reported earlier were re-evaluated, with the aim of gathering the long-term results of pressure-controlled intermittent coronary sinus occlusion (PICSO) generated in patients with acute myocardial infarction (MI) and revascularization.


RESULTS
Thirty-four patients with ST elevated MI, in whom complete revascularization was achieved, underwent primary thrombolysis with or without PICSO. Follow-up data from these patients were collected for at least 48 months. Immediate perioperative differences were observed for time to peak creatine kinase (CK), as well as cumulative CK. In addition, the time until reperfusion was considerably less than for the control group (p=0.014). Long-term data showed significant differences in reinfarction (p=0.015), as well as in major adverse cardiovascular events, between the 2 groups (p<0.0001).


CONCLUSIONS
These data, because of the wide interval between collection and current analysis, could have inherited historical bias. Nonetheless, they are also uniquely indicating the potential of CSI to induce not only immediate, but also clinically significant long-term, effects as an adjunct to reperfusion therapy. Therefore, CSI should be, once again, on the study agenda and be placed under contemporary and best-available scientific scrutiny.
Mohl
Werner
W
Department of Cardiothoracic Surgery, Medical University of Vienna, 1090 Vienna, Waehringerguertel 18-20, Austria. werner.mohl@meduniwien.ac.at
Komamura
Kazuo
K
Kasahara
Hirofumi
H
Heinze
Georg
G
Glogar
Dietmar
D
Hirayama
Atsushi
A
Kodama
Kazuhisa
K
D000368:Aged; D023903:Coronary Restenosis / Q000517:prevention & control; D054326:Coronary Sinus / Q000503:physiopathology*; D003402:Creatine Kinase / Q000097:blood; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000473:pathology / Q000503:physiopathology* / Q000628:therapy*; D015425:Myocardial Reperfusion / Q000379:methods*; D015912:Thrombolytic Therapy; D013997:Time Factors
D003402:Creatine Kinase